Skip to main content

Efficacy and Safety of Phase III Trial of Guselkumab in PsA: Drs. Yusof and Coates

y.yusof@leeds.ac.uk
Jun 04, 2021 6:23 pm

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

×